MGC in Korean supply deal

20/10/2017 - 12:56

Bookmark

Upgrade your subscription to use this feature.

Medical cannabis company MGC Pharmaceuticals has locked in a supply agreement that it expects to net about $20 million in annual revenue.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options